Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Island Pharmaceuticals Limited has disclosed a change in the holdings of director Mr. Albert Hansen. As of April 30, 2024, Hansen’s direct and indirect interest includes over 11 million ordinary shares and options due to the expiry of 400,000 unlisted options. The change in interest, reported in compliance with ASX listing rules, reflects no new acquisitions but an adjustment due to option expiry.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.
